Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAIR: FFR-guided Renal Artery Stenting
NCT06447740Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jun 2024
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Peking University First Hospital. Primary endpoints: Change in daytime mean systolic blood pressure as measured by 24-hour Ambulatory Blood Pressure Monitoring and Change in the composite index of antihypertensive drugs at 3 months. Started Jun 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06447740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06447740.